Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study

NCT00371098 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

658

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

BIOLOGICAL: Influenza vaccination: Influvac (SolvayPharma)
BIOLOGICAL: placebo influenza vaccine

Sponsor

National Institute of Cardiology, Warsaw, Poland

Collaborators

[object Object]